Institute of Cardiovascular and Medical Sciences

Dr David Preiss

  • Clinical Senior Lecturer (Institute of Cardiovascular and Medical Sciences)

telephone: 01413303076
email: David.Preiss@glasgow.ac.uk


David Preiss is a Clinical Senior Lecturer in Metabolic Medicine, based between the BHF Glasgow Cardiovascular Research Centre and the Southern General Hospital. He completed his thesis, examining the links between glycaemia and cardiovascular disease, in 2011/2012 and has recently been awarded the University's Bellahouston medal for this research. His interests lie in the conduct of randomised clinical trials, meta-analyses and epidemiological studies in the area of cardio-metabolic disease including dyslipidaemia and diabetes. Research that has led to international interest includes two major collaborations which established that statin therapy increases the risk of developing new-onset diabetes, plus a further meta-analysis which quantified the effect of intensive glucose control on cardiovascular outcomes. He has also managed the conduct of an important CSO funded placebo-controlled clinical trial, CAMERA, which is designed to investigate the effect of metformin therapy on carotid intima-media thickness, carotid plaques and other surrogate markers of cardiovascular disease in 180 non-diabetic patients with established coronary heart disease. Data from CAMERA will become available in 2013. Other interests include the development of research capabilities in familial hypercholesterolaemia in Scotland and setting up a platform for high-throughput NMR metabolomics. He has led recent publications in JAMA, the Lancet, Diabetes Care, the European Heart Journal and the American Heart Journal and delivered invited lectures at the American Diabetes Association and European Association for the Study of Diabetes annual meetings. He is also co-chair of the Scottish Lipid Forum and has been selected to receive a European Foundation for the Study of Diabetes (EFSD) Rising Star Fellowship for 2013.

Research:

Member:

 

List all by: Type | Date

Jump to: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
Number of items: 38.

2013

Perez, A.C., Jhund, P., Preiss, D., Kjekshus, J., and McMurray, J.J.V. (2013) Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 61 (10). pp. 1121-1122. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.12.004)

Preiss, D. (2013) Triglyceride levels, pancreatitis and choice of lipid-modifying therapy. Expert Review of Gastroenterology and Hepatology, 7 (3). pp. 193-195. ISSN 1747-4124 (doi:10.1586/EGH.12.79)

2012

Preiss, D. et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open, 2 (6). e001925. ISSN 2044-6055 (doi:10.1136/bmjopen-2012-001925)

Preiss, D. (2012) Statin therapy and new-onset diabetes: a cause for concern? Maturitas, 72 (2). pp. 95-96. ISSN 0378-5122 (doi:10.1016/j.maturitas.2012.02.014)

Preiss, D., and Sattar, N. (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9 (4). pp. 190-192. ISSN 1759-5002 (doi:10.1038/nrcardio.2012.15)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 22 (308). pp. 804-811. ISSN 0098-7484 (doi:10.1001/jama.2012.8439)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14 (8). pp. 909-915. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs067)

Sattar, N., and Preiss, D. (2012) HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia, 55 (6). pp. 1564-1567. ISSN 0012-186X (doi:10.1007/s00125-012-2510-8)

2011

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40 (6). pp. 1530-1538. ISSN 0300-5771 (doi:10.1093/ije/dyr172)

Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T., Preiss, D., Sattar, N., Fraser, A., and Waugh, N. (2011) Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15 (38). pp. 1-110. ISSN 1366-5278 (doi:10.3310/hta15380)

Preiss, D., Sesashai, S.R.K., and Ray, K.K. (2011) Statin therapy dose and risk of new-onset diabetes: reply. JAMA: Journal of the American Medical Association, 306 (12). p. 1326. ISSN 0098-7484 (doi:10.1001/jama.2011.1355)

Preiss, D., and Ray, K.K. (2011) Intensive glucose lowering treatment in type 2 diabetes. British Medical Journal, 343 . d4243. ISSN 0959-535X (doi:10.1136/bmj.d4243)

Ghouri, N.A., Preiss, D., and Sattar, N. (2011) Need for a three-focused approach to nonalcoholic fatty liver disease - reply. Hepatology, 53 (5). p. 1774. ISSN 0270-9139 (doi:10.1002/hep.24138)

Ghouri, N, Preiss, D., and Sattar, N. (2011) Reply. Hepatology, 53 (5). p. 1774. ISSN 0270-9139 (doi:10.1002/hep.24138)

Preiss, D., Khunti, K., and Sattar, N. (2011) Combined cardiovascular and diabetes risk assessment in primary care. Diabetic Medicine, 28 (1). pp. 19-22. ISSN 0742-3071 (doi:10.1111/j.1464-5491.2010.03157.x)

Preiss, D., and Sattar, N. (2011) Statins and the risk of new-onset diabetes: a review of recent evidence. Current Opinion in Lipidology, 22 (6). pp. 460-466. ISSN 0957-9672 (doi:10.1097/MOL.0b013e32834b4994)

Preiss, D., and Sattar, N. (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378 (9786). pp. 106-108. ISSN 0140-6736 (doi:10.1016/S0140-6736(11)60819-2)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161 (1). p. 210. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.10.019)

Preiss, D. et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA: Journal of the American Medical Association, 305 (24). pp. 2556-2564. ISSN 0098-7484 (doi:10.1001/jama.2011.860)

2010

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375 (9716). pp. 735-742. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303 (8). pp. 732-733. ISSN 0098-7484 (doi:10.1001/jama.2010.137)

Ghouri, N., Preiss, D., and Sattar, N. (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology, 52 (3). pp. 1156-1161. ISSN 0270-9139 (doi:10.1002/hep.23789)

Preiss, D., and Sattar, N. (2010) HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia, 53 (12). pp. 2468-2469. ISSN 0012-186X (doi:10.1007/s00125-010-1902-x)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31 (10). pp. 1230-1236. ISSN 0195-668X (doi:10.1093/eurheartj/ehq095)

Sattar, N., Preiss, D., Welsh, P., Seshasai, S.R.K., and Ray, K.K. (2010) Statins and risk of incident diabetes Reply. Lancet, 375 (9732). pp. 2141-2142. ISSN 0140-6736

2009

Preiss, D.J., and Sattar, N.A. (2009) Metformin and lactic acidosis Metformin: framed again? British Medical Journal, 339 . b5570. ISSN 0959-535X (doi:10.1136/bmj.b5570)

Preiss, DJ, and Sattar, NA (2009) Authors' reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful. Clinical Endocrinology, 71 (3). pp. 456-457.

Preiss, DJ, and Sattar, NA (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70 (6). pp. 815-828.

Preiss, DJ, and Sattar, NA (2009) Metabolic syndrome: collapsing under its own weight? Diabetic Medicine, 26 (5). pp. 457-459.

Preiss, DJ et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32 (5). pp. 915-920.

Ray, KK, Seshasai, SRK, Wijesuriya, S, Sivakumaran, R, Nethercott, S, Preiss, DJ, Erqou, S, and Sattar, NA (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373 (9677). pp. 1765-1772. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)60697-8)

2008

Preiss, D., Sattar, N., Harborne, L., Norman, J.E., and Fleming, R. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice, 62 (9). pp. 1337-1343. ISSN 13685031 (doi:10.1111/j.1742-1241.2008.01825.x)

Preiss, D., Todd, L., and Panarelli, M. (2008) Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Annals of Clinical Biochemistry, 45 (1). pp. 70-75. ISSN 0004-5632 (doi:10.1258/acb.2007.007100)

Preiss, DJ, and Sattar, NA (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 115 (5-6). pp. 141-150.

2007

Preiss, D.J., Godber, I.M., Lamb, E.J., Dalton, R.N., and Gunn, I.R. (2007) The influence of a cooked-meat meal on estimated glomerular filtration rate. Annals of Clinical Biochemistry, 44 (1). pp. 35-42. ISSN 0004-5632 (doi:10.1258/000456307779595995)

Preiss, D.J., and Sattar, N. (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? International Journal of Clinical Practice, 61 (4). pp. 697-701. ISSN 1368-5031 (doi:10.1111/j.1742-1241.2007.01330.x)

2006

Preiss, D., and Sattar, N. (2006) Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart, 93 (12). pp. 1493-1496. ISSN 1355-6037 (doi:10.1136/hrt.2007.130849)

Preiss, D.J., Godber, I.M., and Gunn, I.R. (2006) How to measure renal function in clinical practice: Eating cooked meat alters serum creatinine concentration and eGFR significantly. BMJ, 333 (7577). p. 1072. ISSN 0959-8138 (doi:10.1136/bmj.39030.730949.3A)

This list was generated on Wed Oct 2 04:50:56 2013 BST.
Jump to: Article
Number of items: 38.

Article

Perez, A.C., Jhund, P., Preiss, D., Kjekshus, J., and McMurray, J.J.V. (2013) Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 61 (10). pp. 1121-1122. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.12.004)

Preiss, D. (2013) Triglyceride levels, pancreatitis and choice of lipid-modifying therapy. Expert Review of Gastroenterology and Hepatology, 7 (3). pp. 193-195. ISSN 1747-4124 (doi:10.1586/EGH.12.79)

Preiss, D. et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open, 2 (6). e001925. ISSN 2044-6055 (doi:10.1136/bmjopen-2012-001925)

Preiss, D. (2012) Statin therapy and new-onset diabetes: a cause for concern? Maturitas, 72 (2). pp. 95-96. ISSN 0378-5122 (doi:10.1016/j.maturitas.2012.02.014)

Preiss, D., and Sattar, N. (2012) Pharmacotherapy: statins and new-onset diabetes—the important questions. Nature Reviews Cardiology, 9 (4). pp. 190-192. ISSN 1759-5002 (doi:10.1038/nrcardio.2012.15)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 22 (308). pp. 804-811. ISSN 0098-7484 (doi:10.1001/jama.2012.8439)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14 (8). pp. 909-915. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs067)

Sattar, N., and Preiss, D. (2012) HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia, 55 (6). pp. 1564-1567. ISSN 0012-186X (doi:10.1007/s00125-012-2510-8)

Ford, I. et al. (2011) The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. International Journal of Epidemiology, 40 (6). pp. 1530-1538. ISSN 0300-5771 (doi:10.1093/ije/dyr172)

Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T., Preiss, D., Sattar, N., Fraser, A., and Waugh, N. (2011) Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15 (38). pp. 1-110. ISSN 1366-5278 (doi:10.3310/hta15380)

Preiss, D., Sesashai, S.R.K., and Ray, K.K. (2011) Statin therapy dose and risk of new-onset diabetes: reply. JAMA: Journal of the American Medical Association, 306 (12). p. 1326. ISSN 0098-7484 (doi:10.1001/jama.2011.1355)

Preiss, D., and Ray, K.K. (2011) Intensive glucose lowering treatment in type 2 diabetes. British Medical Journal, 343 . d4243. ISSN 0959-535X (doi:10.1136/bmj.d4243)

Ghouri, N.A., Preiss, D., and Sattar, N. (2011) Need for a three-focused approach to nonalcoholic fatty liver disease - reply. Hepatology, 53 (5). p. 1774. ISSN 0270-9139 (doi:10.1002/hep.24138)

Ghouri, N, Preiss, D., and Sattar, N. (2011) Reply. Hepatology, 53 (5). p. 1774. ISSN 0270-9139 (doi:10.1002/hep.24138)

Preiss, D., Khunti, K., and Sattar, N. (2011) Combined cardiovascular and diabetes risk assessment in primary care. Diabetic Medicine, 28 (1). pp. 19-22. ISSN 0742-3071 (doi:10.1111/j.1464-5491.2010.03157.x)

Preiss, D., and Sattar, N. (2011) Statins and the risk of new-onset diabetes: a review of recent evidence. Current Opinion in Lipidology, 22 (6). pp. 460-466. ISSN 0957-9672 (doi:10.1097/MOL.0b013e32834b4994)

Preiss, D., and Sattar, N. (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378 (9786). pp. 106-108. ISSN 0140-6736 (doi:10.1016/S0140-6736(11)60819-2)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161 (1). p. 210. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.10.019)

Preiss, D. et al. (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA: Journal of the American Medical Association, 305 (24). pp. 2556-2564. ISSN 0098-7484 (doi:10.1001/jama.2011.860)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375 (9716). pp. 735-742. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303 (8). pp. 732-733. ISSN 0098-7484 (doi:10.1001/jama.2010.137)

Ghouri, N., Preiss, D., and Sattar, N. (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology, 52 (3). pp. 1156-1161. ISSN 0270-9139 (doi:10.1002/hep.23789)

Preiss, D., and Sattar, N. (2010) HbA1c: a useful cardiovascular risk marker in those without diabetes? Diabetologia, 53 (12). pp. 2468-2469. ISSN 0012-186X (doi:10.1007/s00125-010-1902-x)

Preiss, D., Welsh, P., Murray, H., Shepherd, J., Packard, C., Macfarlane, P., Cobbe, S., Ford, I., and Sattar, N. (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up(dagger). European Heart Journal, 31 (10). pp. 1230-1236. ISSN 0195-668X (doi:10.1093/eurheartj/ehq095)

Sattar, N., Preiss, D., Welsh, P., Seshasai, S.R.K., and Ray, K.K. (2010) Statins and risk of incident diabetes Reply. Lancet, 375 (9732). pp. 2141-2142. ISSN 0140-6736

Preiss, D.J., and Sattar, N.A. (2009) Metformin and lactic acidosis Metformin: framed again? British Medical Journal, 339 . b5570. ISSN 0959-535X (doi:10.1136/bmj.b5570)

Preiss, DJ, and Sattar, NA (2009) Authors' reply to: Statin therapy as the fundamental therapy for cardiovascular prevention: be careful. Clinical Endocrinology, 71 (3). pp. 456-457.

Preiss, DJ, and Sattar, NA (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70 (6). pp. 815-828.

Preiss, DJ, and Sattar, NA (2009) Metabolic syndrome: collapsing under its own weight? Diabetic Medicine, 26 (5). pp. 457-459.

Preiss, DJ et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32 (5). pp. 915-920.

Ray, KK, Seshasai, SRK, Wijesuriya, S, Sivakumaran, R, Nethercott, S, Preiss, DJ, Erqou, S, and Sattar, NA (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373 (9677). pp. 1765-1772. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)60697-8)

Preiss, D., Sattar, N., Harborne, L., Norman, J.E., and Fleming, R. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice, 62 (9). pp. 1337-1343. ISSN 13685031 (doi:10.1111/j.1742-1241.2008.01825.x)

Preiss, D., Todd, L., and Panarelli, M. (2008) Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Annals of Clinical Biochemistry, 45 (1). pp. 70-75. ISSN 0004-5632 (doi:10.1258/acb.2007.007100)

Preiss, DJ, and Sattar, NA (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science, 115 (5-6). pp. 141-150.

Preiss, D.J., Godber, I.M., Lamb, E.J., Dalton, R.N., and Gunn, I.R. (2007) The influence of a cooked-meat meal on estimated glomerular filtration rate. Annals of Clinical Biochemistry, 44 (1). pp. 35-42. ISSN 0004-5632 (doi:10.1258/000456307779595995)

Preiss, D.J., and Sattar, N. (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? International Journal of Clinical Practice, 61 (4). pp. 697-701. ISSN 1368-5031 (doi:10.1111/j.1742-1241.2007.01330.x)

Preiss, D., and Sattar, N. (2006) Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart, 93 (12). pp. 1493-1496. ISSN 1355-6037 (doi:10.1136/hrt.2007.130849)

Preiss, D.J., Godber, I.M., and Gunn, I.R. (2006) How to measure renal function in clinical practice: Eating cooked meat alters serum creatinine concentration and eGFR significantly. BMJ, 333 (7577). p. 1072. ISSN 0959-8138 (doi:10.1136/bmj.39030.730949.3A)

This list was generated on Wed Oct 2 04:50:56 2013 BST.

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Metabolic phenotyping to study mechanisms by which metformin might reduce cardiovascular risk
    European Foundation for the Study of Diabetes
    2013 - 2014
     
  • Assessing the predictive value of quantitative high-throughput NMR metabolomic analysis for CVD events in a major study of diabetes: ADVANCE
    Chest, Heart & Stroke, Scotland
    2013 - 2015
     
  • The application of a high-throughput NMR metabolomics system to the study of insulin resistance (ISSF Catalyst)
    Wellcome Trust
    2011 - 2014